Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 302

The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.

Myocardial Viability and Long-Term Outcomes in Ischemic Cardiomyopathy

Open access
Panza, Julio A., Ellis, Alicia M., Al-Khalidi, Hussein R., Holly, Thomas A., Berman, Daniel S., Oh, Jae K., Pohost, Gerald M., Sopko, George, Chrzanowski, Lukasz, Mark, Daniel B., Kukulski, Tomasz, Favaloro, Liliana E., Maurer, Gerald, Farsky, Pedro S., Tan, Ru-San, Asch, Federico M., Velazquez, Eric J., Rouleau, Jean L., Lee, Kerry L., Bonow, Robert O.·2019·New England Journal of Medicine

Abstract

BACKGROUND: The role of assessment of myocardial viability in identifying patients with ischemic cardiomyopathy who might benefit from surgical revascularization remains controversial. Furthermore, although improvement in left ventricular function is one of the goals of revascularization, its relationship to subsequent outcomes is unclear. METHODS: Among 601 patients who had coronary artery disease that was amenable to coronary-artery bypass grafting (CABG) and who had a left ventricular ejection fraction of 35% or lower, we prospectively assessed myocardial viability using single-photon-emission computed tomography, dobutamine echocardiography, or both. Patients were randomly assigned to undergo CABG and receive medical therapy or to receive medical therapy alone. Left ventricular ejection fraction was measured at baseline and after 4 months of follow-up in 318 patients. The primary end point was death from any cause. The median duration of follow-up was 10.4 years. RESULTS: CABG plus medical therapy was associated with a lower incidence of death from any cause than medical therapy alone (182 deaths among 298 patients in the CABG group vs. 209 deaths among 303 patients in the medical-therapy group; adjusted hazard ratio, 0.73; 95% confidence interval, 0.60 to 0.90). However, no significant interaction was observed between the presence or absence of myocardial viability and the beneficial effect of CABG plus medical therapy over medical therapy alone (P = 0.34 for interaction). An increase in left ventricular ejection fraction was observed only among patients with myocardial viability, irrespective of treatment assignment. There was no association between changes in left ventricular ejection fraction and subsequent death. CONCLUSIONS: The findings of this study do not support the concept that myocardial viability is associated with a long-term benefit of CABG in patients with ischemic cardiomyopathy. The presence of viable myocardium was associated with improvement in left ventricular systolic function, irrespective of treatment, but such improvement was not related to long-term survival. (Funded by the National Institutes of Health; STICH ClinicalTrials.gov number, NCT00023595.).

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1056/nejmoa1807365

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 5 references

Cited by

See all 302

Metadata

Authors
Panza, J. A., Ellis, A. M., Al-Khalidi, H. R., Holly, T. A., Berman, D. S., Oh, J. K., Pohost, G. M., Sopko, G., Chrzanowski, L., Mark, D. B., Kukulski, T., Favaloro, L. E., Maurer, G., Farsky, P. S., Tan, R.-S., Asch, F. M., Velazquez, E. J., Rouleau, J. L., Lee, K. L., & Bonow, R. O.
Venue
New England Journal of Medicine
Published
2019-08-22
Volume
381
Issue
8
Pages
739-748
ISSN
  • 0028-4793 (ISSN-L)
  • 1533-4406
OpenAlex
W2969773881
Cited by
302
References
5
FWCI
21.60
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Myocardial Viability and Long-Term Outcomes in Ischemic Cardiomyopathy. https://app.cochat.ai/papers/10.1056/nejmoa1807365
The paper
Panza, J. A., Ellis, A. M., Al-Khalidi, H. R., Holly, T. A., Berman, D. S., Oh, J. K., Pohost, G. M., Sopko, G., Chrzanowski, L., Mark, D. B., Kukulski, T., Favaloro, L. E., Maurer, G., Farsky, P. S., Tan, R.-S., Asch, F. M., Velazquez, E. J., Rouleau, J. L., Lee, K. L., & Bonow, R. O. (2019). Myocardial Viability and Long-Term Outcomes in Ischemic Cardiomyopathy. New England Journal of Medicine. https://doi.org/10.1056/nejmoa1807365

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.